KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amgen (AMGN) Tax Provisions (2016 - 2025)

Historic Tax Provisions for Amgen (AMGN) over the last 17 years, with Q3 2025 value amounting to $705.0 million.

  • Amgen's Tax Provisions rose 16014.76% to $705.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year increase of 17594.65%. This contributed to the annual value of $519.0 million for FY2024, which is 5439.37% down from last year.
  • Amgen's Tax Provisions amounted to $705.0 million in Q3 2025, which was up 16014.76% from $136.0 million recorded in Q2 2025.
  • In the past 5 years, Amgen's Tax Provisions registered a high of $705.0 million during Q3 2025, and its lowest value of $45.0 million during Q1 2024.
  • Over the past 5 years, Amgen's median Tax Provisions value was $214.0 million (recorded in 2022), while the average stood at $228.6 million.
  • Its Tax Provisions has fluctuated over the past 5 years, first tumbled by 9251.25% in 2024, then surged by 44000.0% in 2025.
  • Over the past 5 years, Amgen's Tax Provisions (Quarter) stood at $232.0 million in 2021, then tumbled by 43.1% to $132.0 million in 2022, then crashed by 35.61% to $85.0 million in 2023, then surged by 82.35% to $155.0 million in 2024, then surged by 354.84% to $705.0 million in 2025.
  • Its Tax Provisions stands at $705.0 million for Q3 2025, versus $136.0 million for Q2 2025 and $243.0 million for Q1 2025.